Citations available for content in Chicago, APA and MLA format.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Notice. "Draft Guidance for Industry and Food and Drug Administration Staff; Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses; Availability" Federal Register 74, no. 173 (September 9, 2009): 46433-46434. https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21725.
Office of the Federal Register, National Archives and Records Administration. (). 74 FR 46433 - Draft Guidance for Industry and Food and Drug Administration Staff; Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses; Availability. [Government]. Office of the Federal Register, National Archives and Records Administration. https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21725
Office of the Federal Register, National Archives and Records Administration. 74 FR 46433 - Draft Guidance for Industry and Food and Drug Administration Staff; Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses; Availability. Office of the Federal Register, National Archives and Records Administration, , https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21725
Office of the Federal Register, National Archives and Records Administration, Draft Guidance for Industry and Food and Drug Administration Staff; Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses; Availability, govinfo, (September 9, 2009), https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21725.
Close xFederal Register Volume 74, Issue 173 (September 9, 2009)
Regulatory Information
Federal Register
AE 2.7:
GS 4.107:
AE 2.106:
Office of the Federal Register, National Archives and Records Administration
Notices
Notice.
Although you can comment on any guidance at any time (see 21 CFR 10.115 (g)(5)), to ensure that the agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit written or electronic comments on the draft guidance by December 8, 2009.
Kate Simon, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5552, Silver Spring, MD 20993, 301-796-6204.
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled "Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses." FDA is issuing this draft guidance to inform industry and agency staff of its recommendations for analytical and clinical performance studies to support premarket submissions for in vitro diagnostic devices intended for the detection or detection and differentiation of human papillomaviruses.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
46433-46434
74 FR 46433
Docket No. FDA-2009-D-0386
E9-21725